HCW Biologics Q2 Sales $622.81K Up From $454.00K YoY, Net Loss Of $4.3M Compared To $3.5M Year Ago
Portfolio Pulse from Benzinga Newsdesk
HCW Biologics (NASDAQ:HCWB) reported Q2 sales of $622.81K, a 37.18% increase from $454.00K in the same period last year. However, the company also reported a net loss of $4.3M, compared to a loss of $3.5M a year ago.
August 11, 2023 | 11:17 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
HCW Biologics reported increased Q2 sales but also a larger net loss compared to last year.
While HCW Biologics reported a significant increase in sales, the company's net loss also increased. This mixed financial performance could lead to uncertainty among investors, potentially impacting the stock's short-term price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100